Kevin Kensler, ScD

Highlights

1
Journal of the National Cancer Institute · 2021
KKKevin Kensler
PMID: 33146392PMCID: PMC8168268DOIFirst author84 citations
2
JAMA network open · 2026
AGAaron Gurayah MKManish Kuchakulla JMJialin Mao BABashir Al Hussein+2 more →KKKevin Kensler
PMID: 41979877PMCID: PMC13080545DOISenior author10 citations
3
JAMA network open · 2024
KKKevin Kensler JMJialin Mao
PMID: 38662374PMCID: PMC11046335DOIFirst author7 citations

53

8 grants

PI
Optimizing prostate cancer screening among older men
National Cancer Institute · 2026–2030
R01CA307253-01A1
Co-I
Environmental and social determinants of mammographic features
National Institute of Environmental Health Sciences · 2024–2029 · via Harvard University
R01ES035736-01A1
Sub-PI
DNA Repair Deficiencies in Infertile Men and Cancer Risk
National Cancer Institute · 2024–2029 · via The Children's Mercy Hospital· 2 renewals
R01CA290670-02
Co-I
Structural Racism and Cardiovascular Outcomes Among Cancer Survivors
National Cancer Institute · 2024–2029
R37CA288492-01
Co-I
Cost-Effectiveness of Prostate Cancer Screening in the United States: Evaluating Current Practice and Emerging Strategies
Prostate Cancer Foundation · 2026–2029
25PILO02
PI
Assessing the Impact of GLP-1 Receptor Agonists and SGLT2 Inhibitors on Advanced Prostate Cancer Risk and Outcomes
Prostate Cancer Foundation · 2025–2028
25YOUN29
KP
Center for SOcial CApital (SOCA): Promoting Multigenerational Health
National Cancer Institute · 2023–2028
U54CA280808-01
Co-I
Novel Approach to Improving Prostate Cancer Screening Among African American Men
U.S. Department of Defense · 2022–2026
W81XWH-22-1-0451

Completed grants (4)

PI
Contributions of tumor molecular subtypes to prostate cancer racial disparities
National Cancer Institute · 2021–2025
R00CA245900-05
PI
Contributions of tumor molecular subtypes to prostate cancer racial disparities
NCI · 2020–2022 · via NIH RePORTER
K99CA245900-02
PI
Molecular tumor subtypes and prostate cancer disparities
NCI · 2019–2020 · via NIH RePORTER
F32CA243285-01
PI
Androgen receptor expression and signaling and breast cancer risk and progression
NCI · 2015–2018 · via NIH RePORTER
F31CA192462-03

3

2 studies

PI
Androgen Deprivation Therapy and Risk of Treatment-Related Cardiovascular Complications in Men with Prostate Cancer
Weill Medical College of Cornell University · OPEN TO ACCRUAL (as of 2026)
PI
Surveillance, Epidemiology, and End Results Program Genetic Testing Linkage Database
Weill Medical College of Cornell University · OPEN TO ACCRUAL (as of 2025)

Completed & closed trials (1)

PI
Neighborhood Social Determinants of Health, Comorbidities, and Prostate Cancer Disparities - BRANYplus Transfer
Weill Medical College of Cornell University · CLOSED TO ACCRUAL (as of 2023)

Prostate Cancer Foundation Awards Grants to Weill Cornell Medicine Investigators
March 26, 2026
Six researchers from Weill Cornell Medicine have received Young Investigator Awards from the Prostate Cancer Foundation.
Weill Cornell Medicine Community Celebrates Diversity Champions
April 28, 2023
In a celebration of Weill Cornell Medicine’s commitment to fostering inclusivity in academic medicine, the institution on April 25 honored nearly a dozen faculty, students and staff who exemplify excellence in diversity, equity and inclusion.